OPTIMER PHARMACEUTICALS
Optimer Pharmaceuticals, Inc. (Optimer) is a biopharmaceutical company focused on discovering, developing and commercializing anti-infective products. It has two late-stage anti-infective product candidates, fidaxomicin and Pruvel (prulifloxacin). Optimer's development efforts are focused on products that treat gastrointestinal infections, and related diseases where therapies have limitations. Its product portfolio includes Fidaxomicin, Pruvel, CEM-101, OPT-822/OPT-821 Combination Therapy and OPT-88.
OPTIMER PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
1998-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.optimerpharma.com
Total Employee:
251+
Status:
Closed
Contact:
+8589090737
Total Funding:
66.2 M USD
Technology used in webpage:
Domain Not Resolving Digg Rackspace Cloud Servers LongTail Video
Current Employees Featured
Founder
Stock Details
Investors List
SB Life Science
SB Life Science investment in Series D - Optimer Pharmaceuticals
Strategic Global Investments
Strategic Global Investments investment in Series D - Optimer Pharmaceuticals
Fubon Bank
Fubon Bank investment in Series D - Optimer Pharmaceuticals
China Development Industrial Bank (CDIB)
China Development Industrial Bank (CDIB) investment in Series D - Optimer Pharmaceuticals
ProQuest Investments
ProQuest Investments investment in Series D - Optimer Pharmaceuticals
Lurie Investment Fund
Lurie Investment Fund investment in Series D - Optimer Pharmaceuticals
YFY Biotech Management Company
YFY Biotech Management Company investment in Series D - Optimer Pharmaceuticals
BB Biotech Ventures
BB Biotech Ventures investment in Series D - Optimer Pharmaceuticals
Par Pharmaceuticals
Par Pharmaceuticals investment in Series C - Optimer Pharmaceuticals
China Development Industrial Bank (CDIB)
China Development Industrial Bank (CDIB) investment in Series B - Optimer Pharmaceuticals
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2007-07-01 | Cempra | Optimer Pharmaceuticals investment in Series B - Cempra | 10 M USD |
Official Site Inspections
http://www.optimerpharma.com
Unable to get host informations!!!
